mepa8 Get alerts

FDA warns Ismerely Mire-X joint pain product contains hidden diclofenac and dexamethasone

The agency says the product is sold for joint pain on websites including ebay.com and possibly in some retail stores, and warns that stopping it may carry corticosteroid withdrawal risks.

Mepa8 headline card: FDA warns Ismerely Mire-X joint pain product contains hidden diclofenac and dexamethasone

Key takeaways

  • On November 12, 2026, the FDA advised consumers not to buy or use Ismerely Mire-X, a product sold for joint pain.
  • FDA laboratory analysis found diclofenac, an NSAID, and dexamethasone, a steroid, neither of which is listed on the label.
  • The product is sold on websites including ebay.com and possibly in some retail stores, according to the FDA.
  • The FDA says corticosteroid withdrawal risks should be assessed by a health care professional before the product is stopped.
  • For crews: the record names no lot numbers, manufacturer, or distributor, and the FDA says it cannot test every supplement with hidden ingredients.

The Food and Drug Administration on November 12, 2026 advised consumers not to buy or use Ismerely Mire-X, a product marketed for joint pain, after agency laboratory testing found two prescription drug ingredients that do not appear on the label [1].

According to the FDA notification, the product is promoted and sold on various websites, including ebay.com, and possibly in some retail stores [1]. The agency said its analysis "confirmed that Ismerely Mire-X contains diclofenac and dexamethasone not listed on the product label" [1].

The notice was posted under the FDA's medication health fraud notifications, a series the agency uses to flag products sold as dietary supplements or conventional foods that turn out to contain hidden drug ingredients [1].

What the records show

The FDA record identifies two undeclared ingredients. Diclofenac is a nonsteroidal anti-inflammatory drug, or NSAID, used for pain and inflammation [1]. Dexamethasone is a corticosteroid that the agency describes as commonly used to reduce inflammation [1].

The notification lists the hazards the agency associates with each drug. For diclofenac, the FDA said NSAIDs can raise the risk of serious heart problems, including heart attack and stroke, and can cause serious gastrointestinal harm such as bleeding, ulcers, or tears in the stomach or intestinal lining that can be life-threatening [1]. The agency added that diclofenac can interact with other medications, particularly products that also contain NSAIDs, and that this "may significantly increase the risk of these serious side effects" [1].

For dexamethasone, the FDA said the drug can weaken the immune system and make infections harder to fight, and that it can also cause high blood sugar, muscle damage and mental health problems [1].

The notification directs people who are taking the product to consult a health care professional to stop it safely, and states that "the risks of withdrawal from corticosteroids should be assessed by a health care professional" [1].

The FDA asked health care professionals and consumers to report adverse events tied to the product through its MedWatch program, either online or by downloading the form and faxing it to 1-800-FDA-0178 [1].

The agency framed the notice as part of a broader pattern. Products in this category, it said, are typically promoted for sexual enhancement, weight loss, pain relief and body building and are often represented as all natural [1]. The FDA also stated plainly that it "is unable to test and identify all products marketed as dietary supplements that have potentially harmful hidden ingredients" [1].

Why it matters for EMS

The FDA record describes a product that pairs an unlabeled NSAID with an unlabeled corticosteroid, and that is sold for a common complaint, joint pain, through an open online marketplace [1]. A patient using it may not know they are taking either drug, and the label would not reveal it.

The clinical risks the agency lists are ones field clinicians encounter directly: gastrointestinal bleeding, heart attack, stroke, elevated blood sugar, and infection in a patient whose immune response is suppressed [1]. The FDA also flagged drug interactions when diclofenac is combined with other NSAID-containing products [1]. A medication history that includes "natural" joint supplements bought online would not surface these exposures on its own.

The corticosteroid component adds a second issue the FDA raises explicitly: withdrawal. The agency said the risks of stopping a corticosteroid should be assessed by a health care professional rather than handled by the consumer alone [1]. The record does not describe how long the product has been on the market or how long any user may have been taking it. EMS clinicians follow local protocols and medical direction.

What the records do not tell us

The FDA notification does not name a manufacturer, distributor, or seller beyond the general reference to ebay.com and other websites [1]. It does not list lot numbers, package sizes, label images, or a date range for when the product was sold. It does not say which retail stores, if any, carry it, only that it is "possibly in some retail stores" [1].

The record gives no amounts for the diclofenac or dexamethasone detected, and does not say how many samples were tested or where they were purchased. It does not report any adverse events, injuries, or deaths linked to the product. It does not say whether the FDA has contacted the seller, issued a warning letter, or requested a recall. No company response appears in the record.

The notice is a consumer advisory from the FDA, not a recall announcement from a firm, and the record does not indicate that any recall is underway.

What to watch

The FDA notification asks for adverse event reports through MedWatch [1]. The record does not set out any further regulatory step, deadline, or follow-up document, and does not say whether a recall or enforcement action will follow.

Questions readers ask

What hidden ingredients did the FDA find in Ismerely Mire-X?

FDA laboratory analysis found diclofenac, an NSAID pain reliever, and dexamethasone, a steroid, neither of which is listed on the product label.

Where is Ismerely Mire-X sold?

According to the FDA, the product is promoted and sold for joint pain on various websites, including ebay.com, and possibly in some retail stores. The record does not name specific stores or a manufacturer.

Why is dexamethasone in a supplement dangerous?

The FDA says dexamethasone can weaken the immune system, making infections harder to fight, and can cause high blood sugar, muscle damage and mental health problems. The agency also warns that corticosteroid withdrawal risks should be assessed by a health care professional.

Has Ismerely Mire-X been recalled?

The FDA record is a consumer advisory telling people not to purchase or use the product. It does not describe a recall, a warning letter, or any response from the seller.

Sources

  1. FDA: Ismerely Mire-X may be harmful due to hidden ingredients (Nov. 12, 2026) — fda.gov (2026-11-12). fda.gov/drugs/medication-health-fraud-notifications/ismerely-mire-x-ma
How this story was made Drafted by Mepa8's AI newsroom from the 1 record listed above and nothing else. Before publication a verification program confirmed that every number and quotation in the story appears in those records, that no passage was copied from them, and that every cited link opens. Editor: Ryan Bolden, EMS professional, who reviews published stories and handles corrections. Medical review pending. How we use AI · Report an error

This is news, not medical advice. EMS clinicians: follow your local protocols and medical direction.

Free alerts

Know about the next recall or outbreak the day it is posted.

One email when a story touches EMS equipment, medications or public health. Plus the free 6am briefing if you want it.

Send me